Total (189) | |
---|---|
Sex (male: female) | 105:84 |
Age (years) | 47.1 ± 13.5 |
Primary renal disease | |
Chronic glomerulonephritis (%) | 133 (70.4) |
Diabetic nephropathy (%) | 10 (5.3) |
Hypertensive nephrosclerosis (%) | 21 (11.1) |
Obstructive nephropathy (%) | 8 (4.2) |
Polycystic kidneys (%) | 4 (2.1) |
Other/unknown (%) | 13 (6.9) |
BMI (kg/m2) | 21.0 ± 3.0 |
Diabetes (%) | 23 (12.2) |
CCI | 3.0 ± 1.3 |
Hemoglobin (g/dL) | 8.2 ± 1.6 |
Serum albumin (g/L) | 38.1 ± 5.4 |
hs-CRP (mg/dL) | 2.4 (1.1–4.1) |
Residual GFR (ml/min) | 7.3 ± 2.5 |
urine volume (ml/24 h) | 900 (500–1300) |
Ultrafiltration volume (ml/24) | 250 (100–500) |
Total dialysate volume (L/24 h) | 5.5 ± 1.4 |
Dialysate glucose exposure (g/24 h) | 90 (60–110) |
2.5% glucose solution use (%) | 97 (51.3) |
Peritoneal transport status | |
High (%) | 18 (9.5) |
High average (%) | 57 (30.2) |
Low average (%) | 57 (30.2) |
Low (%) | 20 (10.6) |
PSTR(4 h) | 0.66 ± 0.12 |
Time of PET (months) | 2.7 (1.9–4.7) |
Peritoneal Kt/Vurea | 1.11 ± 0.45 |
Total Kt/Vurea | 2.15 ± 0.56 |
Follow-up (months) | 41.9 (22.4–63.5) |